NOA 2023: Bridging the gap between glaucoma news and patient care

Video

At NOA 2023, Monique Barbour, MD, caught up with Optometry Times to tell us more about her presentation on the latest and greatest in glaucoma.

Monique Barbour, MD, presented a talk entitled, "Glaucoma research and industry news: Potions and procedures," at National Optometric Association 2023 Convention in Fort Lauderdale, Florida.

Video transcript

Editor's note: This transcript has been edited lightly for clarity.

Monique Barbour, MD:
Hi everyone. I'm Dr. Monique Barbour. I'm a board-certified ophthalmologist in West Palm Beach, Florida.

My presentation was titled, "Glaucoma research and industry news: Potions and procedures." It was a very, very good talk, which included all the elements of everything new in glaucoma. We talked first about the types of glaucoma, and this led to a discussion on new medications, new laser treatments, clinical trials, and community outreach programs as well as access to medications and care for glaucoma patients.

I think one of the biggest things that we need to look at now is to take a look at all of the glaucoma studies and trials that are there. One other thing to add is to pay close attention to big data and artificial intelligence and see how it incorporates our treatment profile and management of our patients.

When it comes to the African American community, it's important to tag along with national observances, such as Juneteenth. To get the word out about glaucoma. The key takeaway points are to preserve the ocular surface with the use of preservative-free topical medications. Second, consider a laser treatment or surgical procedure earlier to preserve the best quality of life for our glaucoma patients. Always advocate for our patients' betterment.

I think that it's important to stay in the community and tag along, again, with some of the national observances, such as January: It is glaucoma month. During the month of March, we have a whole week that we commit to creating awareness and advocacy for our glaucoma patients. We certainly do need to keep those in mind. At the same time, we need to exploit all of the services that are available through the various glaucoma foundations and national programs that support our patients.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
© 2025 MJH Life Sciences

All rights reserved.